- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- January 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- May 2025
- 446 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 66 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 90 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 383 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 283 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 73 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 300 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 377 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 170 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 387 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 72 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 284 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 379 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 64 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 553 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 371 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 220 Pages
Global
From €5355EUR$5,850USD£4,551GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more